XML 12 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover Page - shares
3 Months Ended
Mar. 31, 2022
May 09, 2022
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q1  
Entity Registrant Name DAY ONE BIOPHARMACEUTICALS, INC.  
Entity Central Index Key 0001845337  
Entity File Number 001-40431  
Entity Tax Identification Number 83-2415215  
Entity Incorporation, State or Country Code DE  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Address, Address Line One 395 Oyster Point Blvd.  
Entity Address, Address Line Two Suite 217  
Entity Address, City or Town South San Francisco  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94080  
City Area Code 650  
Local Phone Number 484-0899  
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol DAWN  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   61,911,929